— Know what they know.
Not Investment Advice

TMDX NASDAQ

TransMedics Group, Inc.
1W: -6.7% 1M: -15.7% 3M: -10.6% YTD: -43.2% 1Y: -46.6% 3Y: +68.5% 5Y: +157.6%
$69.73
-0.90 (-1.27%)
 
Weekly Expected Move ±6.9%
$61 $66 $71 $76 $81
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 32 · $2.4B mcap · 34M float · 2.63% daily turnover · Short 49% of daily vol
Credit Risk of going bust: higher than 61% of companies Debt: 26.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.76 (down 97%), TransMedics Group, Inc. would be worth roughly what it owes.
Total debt $867.7M against a stock market value of $2.42B.
Distance to default 4.16 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $270.6M (short-term plus half of long-term), stock volatility 58.4%; Altman Z 2.41. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
49.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 18.7%  ·  5Y Avg: 11.1%
Cost Advantage ★
69
Intangibles
38
Switching Cost
52
Network Effect
37
Scale
50
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TMDX shows a Weak competitive edge (49.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 18.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$65
Low
$99
Avg Target
$122
High
Based on 5 analysts since Aug 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 9Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$97.43
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-13 Canaccord Genuity — $95 $94 -1 +20.3% $78.17
2026-10-06 Barclays — Initiated $120 — +49.5% $80.28
2026-08-05 Robert W. Baird — $140 $122 -18 +51.1% $80.75
2026-08-05 Canaccord Genuity — $124 $95 -29 +17.6% $80.75
2026-08-05 Stifel Nicolaus — $80 $65 -15 -19.5% $80.75
2026-08-03 Needham Mike Matson $142 $106 -36 +38.5% $76.51
2026-07-28 UBS — Initiated $80 — +7.7% $74.28
2026-07-06 Evercore ISI Daniel Markowitz $155 $90 -65 +27.2% $70.77
2026-06-18 Stifel Nicolaus — $75 $80 +5 +9.3% $73.22
2026-05-26 Stifel Nicolaus Thomas Stephan $85 $75 -10 +8.8% $68.94
2026-05-06 Needham — $166 $142 -24 +92.3% $73.84
2026-05-06 Canaccord Genuity William Plovanic $148 $124 -24 +30.6% $94.93
2026-05-06 Piper Sandler — $140 $120 -20 +26.4% $94.93
2026-05-06 Stifel Nicolaus Thomas Stephan $130 $85 -45 -10.5% $94.93
2026-05-06 Robert W. Baird David Rescott $120 $140 +20 +47.5% $94.93
2026-03-09 Stifel Nicolaus — Initiated $130 — -3.5% $134.77
2025-12-17 Canaccord Genuity — $147 $148 +1 +18.4% $125.04
2025-12-08 Needham — $148 $166 +18 +21.6% $136.51
2025-12-02 Morgan Stanley — $145 $135 -10 -10.3% $150.42
2025-10-30 Piper Sandler Matt O'Brien $90 $140 +50 +4.2% $134.32
2025-10-30 Canaccord Genuity Jason Mills $109 $147 +38 +9.4% $134.32
2025-10-23 Needham — $109 $148 +39 +23.8% $119.54
2025-10-13 Jefferies — Initiated $145 — +35.1% $107.29
2025-10-07 Evercore ISI — Initiated $155 — +36.0% $113.93
2024-12-11 Robert W. Baird David Rescott $150 $120 -30 +78.1% $67.36
2024-12-11 Piper Sandler Matt O'Brien $180 $90 -90 +33.6% $67.36
2024-10-29 Robert W. Baird Joe Vruwink $200 $150 -50 +69.1% $88.70
2024-10-29 Canaccord Genuity Jason Mills $169 $109 -60 -13.7% $126.24
2024-10-29 Needham Mike Matson $208 $109 -99 -13.7% $126.24
2024-10-29 Oppenheimer Suraj Kalia $200 $125 -75 -1.0% $126.24
2024-09-23 Robert W. Baird David Rescott Initiated $200 — +25.4% $159.50
2024-09-04 Piper Sandler Matt O'Brien $170 $180 +10 +13.6% $158.42
2024-08-21 Needham Mike Matson Initiated $208 — +25.2% $166.18
2024-08-01 Canaccord Genuity William Plovanic Initiated $169 — +3.0% $164.02
2024-08-01 Oppenheimer Suraj Kalia $45 $200 +155 +40.6% $142.26
2024-07-15 Morgan Stanley Patrick Wood $63 $145 +82 +2.0% $142.19
2024-07-15 Piper Sandler Matt O'Brien Initiated $170 — +19.6% $142.19
2024-06-03 Stephens George Sellers Initiated $151 — +13.0% $133.63
2023-01-06 Morgan Stanley — $37 $63 +26 +10.5% $57.02
2022-08-03 Morgan Stanley — $34 $37 +3 -4.2% $38.63
2022-08-02 Oppenheimer — Initiated $45 — +18.5% $37.99
2022-07-26 Cowen & Co. — $39 $45 +6 +27.9% $35.18
2022-06-29 Morgan Stanley — $25 $34 +9 +6.4% $31.96
2022-06-28 Cowen & Co. — Initiated $39 — +15.5% $33.78
2022-05-04 Morgan Stanley — Initiated $25 — -18.4% $30.62

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
1
ROE
5
ROA
5
D/E
1
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TMDX receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-05 B- B
2026-05-11 B B-
2026-04-01 B- B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 62 Grade C
Profitability
64
Balance Sheet
58
Earnings Quality
75
Growth
80
Value
53
Momentum
91
Safety
65
Cash Flow
55
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TMDX scores highest in Momentum (91/100) and lowest in Value (53/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.59
Grey Zone
Piotroski F-Score
3/9
✓ ✓ ✓ ✗ ✗ ✗ ✗ ✗ ✗
Beneish M-Score
-0.82
Possible Manipulator
Ohlson O-Score
-7.26
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 57.5/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 0.96x
Accruals: 0.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TMDX scores 2.59, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TMDX scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TMDX's score of -0.82 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TMDX's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TMDX receives an estimated rating of BBB (score: 57.5/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). TMDX's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.78x
PEG
0.15x
P/S
3.62x
P/B
4.65x
P/FCF
34.21x
P/OCF
18.53x
EV/EBITDA
23.80x
EV/Revenue
4.64x
EV/EBIT
33.04x
EV/FCF
39.21x
Earnings Yield
5.61%
FCF Yield
2.92%
Shareholder Yield
0.00%
Graham Number
$32.66
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.8x earnings, TMDX trades at a reasonable valuation. An earnings yield of 5.6% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $32.66 per share, 113% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
2.091
NI / EBT
×
Interest Burden
0.774
EBT / EBIT
×
EBIT Margin
0.140
EBIT / Rev
×
Asset Turnover
0.568
Rev / Assets
×
Equity Multiplier
2.816
Assets / Equity
=
ROE
36.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TMDX's ROE of 36.3% is driven by Asset Turnover (0.568), indicating efficient use of assets to generate revenue. A tax burden ratio of 2.09 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$143.47
Price/Value
0.46x
Margin of Safety
53.70%
Premium
-53.70%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with TMDX's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. TMDX trades at a -54% premium to its adjusted intrinsic value of $143.47, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 15.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$69.73
Median 1Y
$63.74
5th Pctile
$21.83
95th Pctile
$189.73
Ann. Volatility
69.6%
Analyst Target
$97.43
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Waleed H. Hassanein,
M.D. President and Chief Executive Officer
$776,923 $4,364,013 $10,915,533
Tamer Khayal, M.D.
Former Chief Commercial Officer
$496,316 $1,357,775 $3,750,144
Nicholas Corcoran Supply
Vice President of Supply Chain and Operations
$451,731 $977,573 $2,819,576
Gerardo Hernandez Financial
ancial Officer
$488,462 $271,540 $1,570,572
Anil Ranganath President,
ior Vice President, General Counsel and Corporate Secretary
$412,308 $434,494 $1,503,075

CEO Pay Ratio

53:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,915,533
Avg Employee Cost (SGA/emp): $206,200
Employees: 898

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
898
+23.4% YoY
Revenue / Employee
$674,269
Rev: $605,494,000
Profit / Employee
$211,905
NI: $190,291,000
SGA / Employee
$206,200
Avg labor cost proxy
R&D / Employee
$76,899
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -40.3% -51.5% -59.5% -68.2% -31.7% -28.4% -22.4% -18.1% -22.8% -15.4% -5.8% 1.8% 19.4% 19.4% 23.0% 28.2% 32.5% 54.2% 45.2% 36.3% 36.28%
ROA -26.1% -30.8% -34.7% -37.0% -20.8% -17.6% -13.8% -4.4% -7.4% -5.1% -2.0% 0.4% 4.4% 4.7% 6.3% 8.7% 10.6% 20.3% 15.1% 12.9% 12.88%
ROIC -2.5% -1.6% -1.0% -88.0% -55.6% -46.2% -29.6% -15.5% -14.0% -8.8% -3.5% -0.5% 7.9% 9.1% 10.8% 17.0% 23.2% 42.3% 20.3% 18.7% 18.69%
ROCE -29.5% -36.1% -41.4% -46.3% -15.1% -12.8% -9.4% -1.9% -4.5% -2.4% -0.3% 1.3% 5.0% 5.3% 7.3% 10.1% 12.3% 12.4% 8.0% 6.9% 6.87%
Gross Margin 70.3% 72.3% 76.2% 69.9% 70.5% 66.0% 69.2% 70.0% 61.2% 59.0% 61.8% 60.5% 55.9% 59.2% 61.5% 61.4% 58.8% 58.1% 58.2% 59.6% 59.59%
Operating Margin -2.2% -1.2% -59.0% -47.5% -21.6% -21.6% -5.0% -1.7% -42.7% 3.2% 12.8% 10.9% 3.6% 7.1% 19.1% 23.2% 16.2% 13.2% 7.6% 12.5% 12.50%
Net Margin -2.4% -1.3% -66.5% -56.2% -28.9% -21.4% -6.3% -1.9% -38.3% 5.0% 12.6% 10.7% 3.9% 5.6% 17.9% 22.2% 16.9% 65.6% 4.2% 7.7% 7.73%
EBITDA Margin -2.1% -1.1% -56.1% -47.4% -21.6% -13.5% -0.1% 6.0% -32.3% 13.8% 17.4% 15.0% 12.0% 13.4% 25.3% 29.5% 23.2% 20.2% 15.8% 19.4% 19.41%
FCF Margin -1.1% -1.1% -1.2% -1.0% -84.7% -61.8% -39.4% -27.0% -72.0% -68.2% -68.3% -54.0% -30.0% -18.3% -13.0% 3.3% 21.3% 22.1% 23.8% 11.8% 11.82%
OCF Margin -1.0% -95.4% -1.0% -84.6% -67.5% -49.0% -30.3% -21.7% -13.2% -5.4% -2.6% 6.6% 9.3% 11.1% 10.1% 21.7% 31.4% 31.8% 34.6% 21.8% 21.83%
ROE 3Y Avg snapshot only 17.80%
ROE 5Y Avg snapshot only -10.51%
ROA 3Y Avg snapshot only 6.27%
ROIC Economic snapshot only 12.43%
Cash ROA snapshot only 9.97%
Cash ROIC snapshot only 15.98%
CROIC snapshot only 8.66%
NOPAT Margin snapshot only 25.52%
Pretax Margin snapshot only 10.85%
R&D / Revenue snapshot only 13.83%
SGA / Revenue snapshot only 31.75%
SBC / Revenue snapshot only 5.55%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -24.21 -12.03 -16.07 -18.44 -29.92 -54.53 -86.31 -153.70 -49.91 -107.79 -251.51 1771.71 171.65 61.91 54.86 75.85 49.82 26.16 20.93 17.82 15.776
P/S Ratio 32.48 17.58 19.26 17.11 17.59 21.14 20.51 18.09 9.31 11.17 8.64 14.82 13.97 4.97 5.50 10.23 8.07 8.22 5.66 4.04 3.617
P/B Ratio 11.67 7.84 12.57 17.28 6.72 10.54 12.68 18.82 14.12 19.66 16.08 27.99 26.69 9.60 10.08 17.09 12.87 10.52 7.28 5.22 4.654
P/FCF -30.87 -16.43 -16.59 -16.62 -20.77 -34.23 -52.03 -67.02 -12.92 -16.36 -12.64 -27.43 -46.49 -27.12 -42.47 313.24 37.90 37.27 23.77 34.21 34.209
P/OCF — — — — — — — — — — — 224.09 149.62 44.99 54.38 47.15 25.69 25.82 16.34 18.53 18.529
EV/EBITDA -26.38 -12.84 -18.13 -21.39 -32.54 -64.82 -118.34 -399.10 -83.01 -392.60 281.49 231.17 99.59 37.61 35.01 49.61 34.97 33.40 28.62 23.80 23.798
EV/Revenue 30.08 15.98 18.58 16.85 15.68 19.71 19.43 17.65 9.77 11.67 9.19 15.24 14.44 5.38 5.93 10.45 8.17 8.19 6.29 4.64 4.636
EV/EBIT -24.99 -11.99 -16.91 -19.81 -29.28 -56.79 -94.97 -216.34 -64.53 -177.51 -1418.27 603.76 159.43 60.31 50.65 65.90 43.28 40.89 37.44 33.04 33.040
EV/FCF -28.58 -14.93 -16.00 -16.37 -18.52 -31.91 -49.30 -65.37 -13.57 -17.10 -13.46 -28.23 -48.05 -29.37 -45.77 320.05 38.34 37.13 26.43 39.21 39.207
Earnings Yield -4.1% -8.3% -6.2% -5.4% -3.3% -1.8% -1.2% -0.7% -2.0% -0.9% -0.4% 0.1% 0.6% 1.6% 1.8% 1.3% 2.0% 3.8% 4.8% 5.6% 5.61%
FCF Yield -3.2% -6.1% -6.0% -6.0% -4.8% -2.9% -1.9% -1.5% -7.7% -6.1% -7.9% -3.6% -2.2% -3.7% -2.4% 0.3% 2.6% 2.7% 4.2% 2.9% 2.92%
PEG Ratio snapshot only 0.145
Price/Tangible Book snapshot only 5.338
EV/OCF snapshot only 21.236
EV/Gross Profit snapshot only 7.898
Acquirers Multiple snapshot only 37.975
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $32.66
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 7.89 5.11 5.22 4.18 12.11 10.66 9.14 20.70 10.93 9.30 9.72 9.37 8.20 8.30 9.10 9.86 7.69 7.14 6.74 6.62 6.625
Quick Ratio 6.95 4.47 4.40 3.41 11.21 9.79 8.30 19.74 10.13 8.49 8.76 8.48 7.33 7.52 8.32 9.17 7.13 6.59 6.19 6.07 6.074
Debt/Equity 0.45 0.65 0.75 0.88 0.36 0.36 0.35 3.55 4.08 3.76 3.24 2.72 2.47 2.27 1.95 1.63 1.46 0.99 1.75 1.67 1.675
Net Debt/Equity -0.86 -0.72 -0.45 -0.26 -0.73 -0.71 -0.66 -0.46 0.70 0.88 1.04 0.81 0.90 0.79 0.78 0.37 0.15 -0.04 0.81 0.76 0.763
Debt/Assets 0.27 0.32 0.36 0.38 0.25 0.24 0.23 0.75 0.75 0.73 0.71 0.68 0.66 0.64 0.62 0.58 0.55 0.44 0.60 0.59 0.593
Debt/EBITDA -1.09 -1.16 -1.13 -1.11 -1.96 -2.38 -3.44 -77.10 -22.84 -71.86 53.22 21.83 8.91 8.20 6.27 4.63 3.93 3.16 6.18 6.66 6.664
Net Debt/EBITDA 2.11 1.29 0.67 0.32 3.95 4.70 6.55 10.06 -3.92 -16.87 17.12 6.50 3.23 2.87 2.52 1.06 0.40 -0.13 2.87 3.03 3.034
Interest Coverage -8.78 -10.40 -11.06 -11.55 -10.68 -8.95 -6.49 -2.29 -3.54 -1.47 -0.14 0.63 2.51 2.74 4.00 5.97 7.63 8.80 6.11 4.42 4.416
Equity Multiplier 1.67 1.99 2.07 2.30 1.46 1.48 1.49 4.75 5.45 5.15 4.54 3.99 3.74 3.52 3.14 2.80 2.66 2.26 2.90 2.83 2.827
Cash Ratio snapshot only 4.809
Debt Service Coverage snapshot only 6.131
Cash to Debt snapshot only 0.545
FCF to Debt snapshot only 0.091
Defensive Interval snapshot only 677.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.19 0.21 0.29 0.40 0.35 0.45 0.58 0.37 0.40 0.49 0.59 0.50 0.54 0.58 0.63 0.64 0.65 0.65 0.56 0.57 0.568
Inventory Turnover 0.66 0.68 0.75 0.93 1.21 1.59 1.83 1.95 2.24 2.70 3.08 3.56 3.57 3.96 4.31 4.88 4.65 5.09 5.58 5.94 5.938
Receivables Turnover 5.48 4.73 4.09 5.34 5.48 5.57 4.73 4.99 4.64 5.30 4.93 5.58 5.32 5.47 4.36 5.71 6.63 6.65 5.46 6.40 6.397
Payables Turnover 5.33 2.32 5.04 3.51 7.01 5.64 10.24 7.34 8.16 10.90 16.49 14.07 12.58 15.62 19.98 18.93 17.79 23.51 23.93 6.81 6.815
DSO 67 77 89 68 67 66 77 73 79 69 74 65 69 67 84 64 55 55 67 57 57.1 days
DIO 551 537 490 391 302 230 200 187 163 135 118 102 102 92 85 75 78 72 65 61 61.5 days
DPO 68 158 72 104 52 65 36 50 45 33 22 26 29 23 18 19 21 16 15 54 53.6 days
Cash Conversion Cycle 549 457 506 355 317 230 241 211 197 171 170 142 142 136 150 119 113 111 117 65 65.0 days
Fixed Asset Turnover snapshot only 0.951
Operating Cycle snapshot only 118.5 days
Cash Velocity snapshot only 1.414
Capital Intensity snapshot only 2.191
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 17.3% 18.0% 55.3% 71.8% 1.5% 2.1% 2.0% 1.9% 1.7% 1.6% 1.5% 1.4% 1.1% 82.7% 64.4% 48.1% 41.2% 37.1% 30.2% 25.8% 25.82%
Net Income -19.8% -53.8% -68.5% -59.1% -11.4% 18.1% 39.6% 62.7% 15.2% 30.9% 64.0% 1.2% 1.9% 2.4% 5.8% 22.9% 1.8% 4.4% 2.5% 1.1% 1.12%
EPS -17.4% -50.4% -65.0% -57.1% -2.1% 28.9% 47.7% 68.0% 21.4% 35.3% 66.5% 1.2% 1.8% 2.4% 5.2% 19.8% 1.5% 3.6% 2.9% 1.1% 1.11%
FCF 3.7% -5.4% -53.3% -98.0% -1.0% -78.3% -3.4% 23.0% -1.3% -1.9% -3.3% -3.8% 12.8% 50.9% 68.8% 1.1% 2.0% 2.7% 3.4% 3.6% 3.56%
EBITDA -23.8% -62.6% -80.1% -66.4% -7.4% 24.5% 51.2% 83.5% 34.7% 74.7% 1.5% 4.5% 3.6% 9.8% 7.5% 3.7% 1.3% 1.3% 69.0% 16.3% 16.33%
Op. Income -16.5% -49.4% -70.0% -56.9% -5.9% 20.3% 42.9% 63.7% -5.9% 8.6% 41.1% 94.8% 1.8% 2.3% 4.7% 96.4% 2.1% 1.9% 79.8% 6.6% 6.57%
OCF Growth snapshot only 26.59%
Asset Growth snapshot only 64.44%
Equity Growth snapshot only 62.86%
Debt Growth snapshot only 67.25%
Shares Change snapshot only 0.37%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — 1.1% 77.3% 70.3% 65.1% 84.2% 99.7% 1.1% 1.3% 1.3% 1.4% 1.4% 1.3% 1.2% 99.1% 86.4% 74.8% 64.2% 64.17%
Revenue 5Y — — — — — — — — — — — 1.3% 98.9% 87.7% 79.1% 85.5% 88.1% 88.2% 90.8% 86.1% 86.11%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — 1.2% 89.7% 79.5% 71.8% 92.1% 1.0% 1.1% 1.2% 1.2% 1.3% 1.3% 1.2% 1.0% 87.8% 77.1% 66.1% 55.5% 55.51%
Gross Profit 5Y — — — — — — — — — — — 1.3% 99.4% 87.5% 78.2% 84.8% 85.5% 85.2% 86.7% 80.9% 80.88%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — -1.0% 34.6% 38.1% 43.6% 61.7% 62.9% 66.8% 70.6% 75.4% 81.6% 81.3% 89.0% 96.5% 51.0% 56.8% 71.0% 28.5% 28.49%
Assets 5Y — — — — — — — — — — — 44.4% 47.5% 50.2% 53.9% 40.4% 42.8% 47.7% 58.0% 59.8% 59.80%
Equity 3Y — — — -10.6% 43.6% 50.8% 60.4% 8.5% 4.9% 9.7% 17.8% 28.7% 38.8% 49.9% 64.4% 84.2% 23.7% 36.2% 36.9% 52.8% 52.80%
Book Value 3Y — — — -30.5% 27.4% 31.4% 39.5% -2.9% -1.3% 1.6% 8.8% 18.7% 27.5% 38.5% 46.0% 62.7% 11.9% 25.5% 31.7% 41.8% 41.81%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.93 0.99 0.67 0.96 0.82 0.73 0.70 0.77 0.81 0.83 0.86 0.71 0.74 0.77 0.79 0.83 0.87 0.90 0.93 0.95 0.954
Earnings Stability 0.95 0.84 0.35 0.80 0.93 0.51 0.00 0.10 0.62 0.01 0.35 0.08 0.20 0.38 0.59 0.67 0.67 0.63 0.72 0.82 0.822
Margin Stability 0.93 0.92 0.91 0.90 0.92 0.93 0.93 0.93 0.95 0.95 0.93 0.91 0.91 0.92 0.91 0.91 0.92 0.93 0.93 0.92 0.924
Rev. Growth Consistency 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
Earnings Persistence 0.92 0.50 0.50 0.50 0.95 0.93 0.84 0.50 0.94 0.88 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — 0.00 0.05 0.00 0.00 0.28 0.283
ROE Trend -0.20 -0.27 -0.26 -0.62 0.16 0.27 0.39 0.51 0.07 0.24 0.40 0.55 0.41 0.34 0.29 0.28 0.32 0.42 0.29 0.17 0.172
Gross Margin Trend 0.06 0.08 0.09 0.08 0.06 0.02 -0.01 -0.01 -0.03 -0.06 -0.08 -0.10 -0.10 -0.07 -0.06 -0.05 -0.02 -0.02 -0.02 -0.02 -0.015
FCF Margin Trend 0.28 0.19 0.06 0.04 0.32 0.52 0.78 0.69 0.23 0.16 0.09 0.11 0.48 0.47 0.41 0.44 0.72 0.65 0.64 0.37 0.372
Sustainable Growth Rate — — — — — — — — — — — 1.8% 19.4% 19.4% 23.0% 28.2% 32.5% 54.2% 45.2% 36.3% 36.28%
Internal Growth Rate — — — — — — — — — — — 0.4% 4.6% 4.9% 6.7% 9.5% 11.9% 25.5% 17.8% 14.8% 14.79%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.78 0.65 0.85 0.91 1.15 1.26 1.27 1.84 0.71 0.52 0.77 7.91 1.15 1.38 1.01 1.61 1.94 1.01 1.28 0.96 0.962
FCF/OCF 1.01 1.12 1.14 1.22 1.25 1.26 1.30 1.24 5.45 12.66 26.01 -8.17 -3.22 -1.66 -1.28 0.15 0.68 0.69 0.69 0.54 0.542
FCF/Net Income snapshot only 0.521
OCF/EBITDA snapshot only 1.121
CapEx/Revenue 1.2% 11.6% 13.9% 18.4% 17.2% 12.7% 9.1% 5.3% 58.8% 62.8% 65.7% 60.6% 39.4% 29.4% 23.1% 18.4% 10.1% 9.8% 10.8% 10.0% 10.01%
CapEx/Depreciation snapshot only 1.836
Accruals Ratio -0.06 -0.11 -0.05 -0.03 0.03 0.05 0.04 0.04 -0.02 -0.02 -0.00 -0.03 -0.01 -0.02 -0.00 -0.05 -0.10 -0.00 -0.04 0.00 0.005
Sloan Accruals snapshot only 0.013
Cash Flow Adequacy snapshot only 2.182
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.2% -0.3% -0.2% -0.1% -11.3% -7.2% -6.0% -5.4% -0.3% -0.3% -0.2% -0.3% -0.4% -1.0% -0.7% -0.3% -0.2% -0.3% -0.5% -0.4% -0.44%
Total Shareholder Return -0.2% -0.3% -0.2% -0.1% -11.3% -7.2% -6.0% -5.4% -0.3% -0.3% -0.2% -0.3% -0.4% -1.0% -0.7% -0.3% -0.2% -0.3% -0.5% -0.4% -0.44%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.96 0.94 0.87 2.03 1.00 0.99 0.98 0.97 0.99 1.77 1.92 2.09 2.091
Interest Burden (EBT/EBIT) 1.11 1.10 1.09 1.09 1.10 1.11 1.16 1.44 1.28 1.68 6.05 0.16 0.90 0.91 0.88 0.88 0.87 0.89 0.84 0.77 0.774
EBIT Margin -1.20 -1.33 -1.10 -0.85 -0.54 -0.35 -0.20 -0.08 -0.15 -0.07 -0.01 0.03 0.09 0.09 0.12 0.16 0.19 0.20 0.17 0.14 0.140
Asset Turnover 0.19 0.21 0.29 0.40 0.35 0.45 0.58 0.37 0.40 0.49 0.59 0.50 0.54 0.58 0.63 0.64 0.65 0.65 0.56 0.57 0.568
Equity Multiplier 1.54 1.67 1.71 1.84 1.52 1.61 1.63 4.12 3.07 3.03 2.87 4.32 4.38 4.13 3.67 3.25 3.06 2.67 2.99 2.82 2.816
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.37 $-1.59 $-1.68 $-1.71 $-1.40 $-1.13 $-0.88 $-0.55 $-1.10 $-0.73 $-0.29 $0.09 $0.91 $1.01 $1.23 $1.77 $2.25 $4.65 $4.75 $3.73 $3.73
Book Value/Share $2.84 $2.44 $2.14 $1.82 $6.21 $5.85 $5.97 $4.46 $3.88 $4.01 $4.60 $5.38 $5.88 $6.49 $6.67 $7.84 $8.72 $11.56 $13.65 $12.73 $14.98
Tangible Book/Share $2.84 $2.44 $2.14 $1.82 $6.21 $5.85 $5.97 $4.46 $3.45 $3.59 $4.19 $4.99 $5.50 $6.10 $6.33 $7.51 $8.38 $11.23 $13.33 $12.44 $12.44
Revenue/Share $1.02 $1.09 $1.40 $1.84 $2.37 $2.92 $3.69 $4.64 $5.88 $7.07 $8.56 $10.17 $11.24 $12.54 $12.23 $13.10 $13.90 $14.79 $17.57 $16.42 $19.33
FCF/Share $-1.07 $-1.17 $-1.62 $-1.89 $-2.01 $-1.80 $-1.46 $-1.25 $-4.24 $-4.82 $-5.85 $-5.49 $-3.38 $-2.30 $-1.58 $0.43 $2.96 $3.26 $4.18 $1.94 $2.29
OCF/Share $-1.06 $-1.04 $-1.43 $-1.55 $-1.60 $-1.43 $-1.12 $-1.01 $-0.78 $-0.38 $-0.22 $0.67 $1.05 $1.39 $1.24 $2.84 $4.37 $4.71 $6.08 $3.58 $4.22
Cash/Share $3.71 $3.33 $2.58 $2.08 $6.76 $6.28 $6.06 $17.89 $13.10 $11.55 $10.10 $10.28 $9.25 $9.56 $7.77 $9.88 $11.44 $11.93 $12.76 $11.61 $13.67
EBITDA/Share $-1.16 $-1.36 $-1.43 $-1.45 $-1.14 $-0.89 $-0.61 $-0.21 $-0.69 $-0.21 $0.28 $0.67 $1.63 $1.80 $2.07 $2.76 $3.25 $3.63 $3.86 $3.20 $3.20
Debt/Share $1.27 $1.58 $1.62 $1.61 $2.24 $2.11 $2.09 $15.82 $15.81 $15.10 $14.89 $14.64 $14.52 $14.72 $12.99 $12.79 $12.75 $11.48 $23.86 $21.32 $21.32
Net Debt/Share $-2.45 $-1.75 $-0.96 $-0.47 $-4.52 $-4.17 $-3.97 $-2.06 $2.71 $3.54 $4.79 $4.36 $5.27 $5.16 $5.22 $2.92 $1.30 $-0.46 $11.10 $9.70 $9.70
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.591
Altman Z-Prime snapshot only 5.337
Piotroski F-Score 2 3 3 3 5 4 4 3 3 3 4 6 6 7 6 8 7 6 6 3 3
Beneish M-Score -3.33 -3.22 -1.93 -1.42 1.17 0.17 -0.34 -0.56 3.56 3.41 0.43 4.55 -1.96 -2.10 -1.88 -2.41 -2.93 -0.74 -1.25 -0.82 -0.822
Ohlson O-Score snapshot only -7.256
ROIC (Greenblatt) snapshot only 7.47%
Net-Net WC snapshot only $-7.25
EVA snapshot only $79315507.96
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB
Credit Score 57.83 32.63 43.71 44.80 62.80 63.60 62.06 50.16 40.46 45.93 36.26 52.03 59.07 48.78 61.95 74.13 81.81 84.10 68.69 57.53 57.534
Credit Grade snapshot only 9
Credit Trend snapshot only -16.596
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 53
Sector Credit Rank snapshot only 50

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms